Swedish Orphan Biovitrum AB Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB ADR
Stock Exchange	Other OTC
EPS	$0.83
Market Cap	$7.76 B
Shares Outstanding	273.32 M
Public Float	-

Swedish Orphan Biovitrum AB
Stock Exchange	OTC Publication Venue
EPS	SEK10.15
Market Cap	SEK55.1 B
Shares Outstanding	297.52 M
Public Float	162.03 M

Profile

Address	Tomtebodavägen 23A Solna AB 112 76 Sweden
Employees	-
Website	http://www.sobi.com
Updated	07/08/2019
Swedish Orphan Biovitrum AB engages as a biopharmaceutical company. It provides therapies and services for patients with rare diseases. The firm's core products include Kineret within the inflammation therapeutic area; and Orfadin, Ammonaps, and Ammonul within the genetics and metabolic therapeutic area.

Financials

Lena Elisabeth Svanberg

Director

David Allsopp

Director